Journal Report

Current Medical Research and Opinion

Download PDF
Journal Information
Journal Title
Current Medical Research and Opinion
Publisher
Taylor and Francis Ltd.
ISSN
0300-7995
E-ISSN
1473-4877
Database
SCOPUS
Domain
Health Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Primary immune thrombocytopenia in Italy: epidemiology, management pathways, and the clinical–economic impact of corticosteroids
Diletta Valsecchi, Roberta Bini, Tommaso Salvini et al.
2026-11-1 Pages 1-16
DOI: 10.1080/03007995.2026.2755148
Cost-effectiveness of cladribine tablets for the treatment of active relapsing-remitting multiple sclerosis in the United Kingdom
Michelle Jones, Stamatia T. Alexopoulos, Anna-Maria Fontrier et al.
2026-10-22 Pages 1-17
DOI: 10.1080/03007995.2026.2734647
Over-the-counter topical diclofenac in musculoskeletal pain: clinical value, access and responsible use
Bart Morlion, Lothar Seefried, Evert Verhagen
2026-10-22 Pages 1-7
DOI: 10.1080/03007995.2026.2746838
Advances in disease management and treatment outcomes for obesity and knee osteoarthritis in primary care practice
Amanda E. Nelson, Leigh F. Callahan, Thomas J. Schnitzer et al.
2026-10-15 Pages 1-14
DOI: 10.1080/03007995.2026.2741495
Associations of the aggregate index of systemic inflammation (AISI) with myocardial injury markers in patients with coronary heart disease
Xuan Liu, Yuchao Wang, Hao Liu et al.
2026-10-14 Pages 1-11
DOI: 10.1080/03007995.2026.2743357
Patient and caregiver burden after hospitalization with severe viral lower respiratory tract disease: results from a real-world survey in Europe, the US and Japan
Anthony C. Gordon, Lynda Draffan, Yao Qiao et al.
2026-10-8 Pages 1-16
DOI: 10.1080/03007995.2026.2741493
Authors’ response to the letter to the editor regarding “Carbon dioxide equivalent emissions and cost impact of non-clinically driven inhaler initiation or switch for COPD”
Krishnali Parsekar, Georgios Xydopoulos, Abdelhamid Yousef et al.
2026-10-8 Pages 1-3
DOI: 10.1080/03007995.2026.2736356
Dapagliflozin and ventricular repolarization across heart failure phenotypes
Gülüzar Traş, Fuat Polat, Melike Saday Bozkurt et al.
2026-10-7 Pages 1-10
DOI: 10.1080/03007995.2026.2741494
Impact of PD-1 and PD-L1 inhibitors on patient-reported outcomes in esophageal squamous cell carcinoma: a systematic review of clinical trials
Sun A. Choi, Wesley J. Wong, Frederick B. Barnes et al.
2026-10-6 Pages 1-14
DOI: 10.1080/03007995.2026.2740280
Transparent scientific evidence is key to developing climate-conscious strategies for inhalers: a letter to the editor in response to “carbon dioxide equivalent emissions and cost impact of non-clinically driven inhaler initiation or switch for COPD”
Christian Grah, Stephan Walterspacher, Guido Schmiemann
2026-9-26 Pages 1-3
DOI: 10.1080/03007995.2026.2734640
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 7, 2026 23:14